drugset / Trial / NCT04192266

Estrogen and Fear in PTSD

NCT04192266

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this research study is to determine if taking a pill of estradiol (E2) together with prolonged exposure (PE) therapy can improve this treatment outcome in women diagnosed with Post-Traumatic Stress Disorder (PTSD). 80 subjects will take part in this research study across UTHealth Houston and UPenn (40 subjects at each site). Participants will be randomized into one of two groups, PE + E2 or PE + placebo. The study will include preliminary screening and baseline visits, experimental visits, and therapy visits over the course of six weeks. Several follow-up visits will take place.

Timeline

Start
2020-06-24
Primary completion
2024-05-29
Completion
2024-12-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 2 mg Oral